I am sure I have heard Colin mention this a couple of times, but he see's the CEO role to deliver turnover and profit and report this at the end of the year - with this being his focus, then makes it a bit clearer why the SP movement isn't really much of a concern.
I don't love that approach - something more upbeat would be better but that's my selfish view as a shareholder (and why it irked me the rampy tweeting that went on around the director sells!)
RE: why Government is taking time to assign £374M to ODX?07 Jun 2021 16:43
Rocquet - AVCT's test has only been tested by themselves - nothing shared........you don't even know which Spanish hospital.
All companies when they do their own clinical studies 'happen' to come out with amazing results. Look at Innova - theirs came out at 99.8%. Then look at Roche in fact, all the other tests - always very high when they do it themself.
Now look when its independently tests it - the performance is always reduced.
I see AVCT banging on about their gold standard test, but when you compare their own clinical study to other companies clinical studies, it is about on par. So lets see how the third party studies get on first - until then, it is a good test I am sure, but as yet, not verified and not going to be accepted by UKGOV until its been tested and as per the RNS's, their is a stumbling block with the frozen samples (that no-one else has an issue with!).
You now have moved from anticipation stage to now deliver - people will be clambering for all these sales and deals promised - but I suspect that will take time. I also think AVCT's presentation being on the 21st is significant.
rocquet - what are you arguing? AVCT clearly stated in both their RNS in Feb and in the full accounts yesterday that they are unlikely to pass at Porton Down due to the testing method (interestingly the only company to complain about this).
Mologic has not shared anywhere that they have not progressed at Porton Down.
its not failed at all - they have a govt contract for £374m. They have millions of ABC-19 tests produced (and continuing to be manufactured) and two chunky antibody test tenders - and with that will come home use approval.
They have to be quiet right now as everything is confidential - it hasn't been managed well at all, but the fact remains we have a lot of money coming ODX's way very soon.
I honestly think they have had their knuckles rapped - partially the Tesla, but some of the others especially the one about the elections which drove the 15% rise. Silence is probably best when so close to getting contracts (and test to manufacture) confirmed.
Lets face it, with regard to LFT (and potentially ELISA testing) we are going to be all but nationalised!
worst case scenario is that the contract is cancelled and we only recieve £50m of the £374.
Two steps: 1. A test must be chosen which we presume must be imminent 2. Then they quarterly are advised how many tests the government wants - thus there is potential that the volume demanded may reduce - I don't suppose that Omega will advise each quarters government volumes
That is why the SP is dropping - the contract was dropped months ago and we seem no clearer as to which test we will be making and thus their is a risk until points 1 & 2 are confirmed.